A groundbreaking report from the WHO Regional Office for Europe reveals how powerful industries are driving the non-communicable disease crisis across Europe and central Asia. The report calls for urgent action to protect public health policies from corporate interference.
The very nature of healthcare, and in particular, pharma, makes sustainability particularly challenging. Patient safety and drug efficacy should remain the greatest priority for healthcare organisations and practitioners, but how do we find the balance between creating a more sustainable future in the drug delivery device sector while also maintaining product quality and safety?
Faced with overcrowding, underinvestment, and the pandemic’s impacts, NHS hospitals are seeking innovative ways to optimize their overburdened facilities. Penny Brinsley looks at one promising solution: Strategic space management enabled by specialized software.
Dr Jerome Fischer, endocrinologist, explores how Artificial Intelligence is advancing continuous glucose monitoring and revolutionizing diabetes treatment.
As the world grapples with the far-reaching consequences of climate change, an unlikely contributor to greenhouse gas emissions emerges: the healthcare sector. A recent study [1] delves into the intricate web connecting healthcare systems and climate change, shedding light on the urgent need for transformative action to mitigate the sector’s environmental footprint.
A team of infectious diseases experts is calling for more awareness and preparedness in the medical field to deal with the impact of climate change on the spread of diseases. Their article, published in JAMA [1] raises the alarm about the emergence and spread of harmful pathogens. The authors also urge the medical community to […]
New results from the I-SPY2 phase 2 clinical trial
The vast majority of young patients given a low-dose boost of radiotherapy to the site where their breast cancer was removed in addition to whole breast radiotherapy, remained free of local recurrence after ten years, according to results of the ‘Young boost trial’ presented at the 14th European Breast Cancer Conference.
Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to primary systemic treatment
Human artificial chromosomes (HACs) capable of working within human cells could power advanced gene therapies, including those addressing some cancers, along with many laboratory applications, though serious technical obstacles have hindered their development. Now a team led by researchers at the Perelman School of Medicine at the University of Pennsylvania has made a significant breakthrough […]
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
WHO